Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34718466.
- Also identified by DOI 10.1093/cid/ciab917 and PMC identifier 9402647.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vaccination rates among patients with CDs need to be improved.
Medical subject headings
- Meningococcal Infections
- Meningococcal Vaccines
- Primary Immunodeficiency Diseases